-
241
Protective effects of wogonin in the treatment of central nervous system and degenerative diseases
Published 2025-02-01“…However, despite the substantial preclinical evidence, further large-scale clinical studies are necessary. …”
Get full text
Article -
242
Developing and validating a drug recommendation system based on tumor microenvironment and drug fingerprint
Published 2025-01-01“…By bridging preclinical IC50 and clinical BOR endpoints, this approach provides a promising tool for optimizing patient-specific treatments.…”
Get full text
Article -
243
Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
Published 2025-06-01“…No significant safety concerns have been identified in preclinical studies involving CBD and THC. However, the available data on the toxicity of combined CBD and THC are still inconclusive. …”
Get full text
Article -
244
Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research
Published 2025-03-01“…We highlight the various approaches to generate them, factors that are critical to successfully establishing such models, their respective limitations, and considerations in model selection for preclinical lung cancer immuno-oncology research and therapeutic studies.…”
Get full text
Article -
245
Detection Performance of 99mTc in Albira SI Small-Animal SPECT-CT
Published 2025-02-01“…Small-animal single-photon emission computed tomography-X-ray computed tomography (SPECT-CT) is an advanced imaging tool for preclinical research of single-photon radiopharmaceuticals. …”
Get full text
Article -
246
Trends in Anti-Epileptic Drug Development
Published 1990-01-01“…More recently, increased attention has been focused on the role which excitatory transmitters may play in epileptogenesis, and various substances which decrease excitation are currently being investigated at the preclinical level. Since considerable potential still resides in several of the drugs already on the market, resources have been spent on trying to modify/improve the chemical formula of some of these substances, and a number of new drugs has emerged as a result of this approach. …”
Get full text
Article -
247
Innovative Approaches to Suppressing Pseudomonas aeruginosa Growth and Virulence: Current Status and Future Directions
Published 2024-01-01“…Additionally, novel approaches, including RNA interference, CRISPR-Cas systems, and nanotechnology, show promise in preclinical studies. Despite advancements, challenges persist, prompting the need for a multifaceted approach targeting various aspects of P. aeruginosa pathogenesis for effective infection management. …”
Get full text
Article -
248
Hypertension and Its Impact on Stroke Recovery: From a Vascular to a Parenchymal Overview
Published 2019-01-01“…This attractive topic remains a focus of continued investigation and stresses the relevance of including this vascular risk factor in preclinical investigations of stroke outcome.…”
Get full text
Article -
249
Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus
Published 2017-01-01“…Here, we review clinical and preclinical studies that provide evidence both for and against a causal role for the SCN in mood disorders.…”
Get full text
Article -
250
Oncolytic Immunotherapy: Where Are We Clinically?
Published 2014-01-01“…Following a century of preclinical and clinical work, oncolytic viruses are now proving themselves in randomized phase 3 trials. …”
Get full text
Article -
251
Characterisation of Chemical Constitutes and Spermatogenic Activity of Ushir (Vetiveria Zizanioides Linn) versus Ikshu (Saccharum Officinarum Linn) in Male Wistar Rats: A Research...
Published 2025-01-01“…Standardisation of Ayurvedic medicines at the pharmaceutical and analytical levels is important for proceeding with preclinical or clinical studies. The outcomes of animal research have helped consider the drug’s benefits and drawbacks. …”
Get full text
Article -
252
The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential
Published 2024-12-01“…However, despite promising preclinical data, rigorous clinical trials are needed to verify their safety and efficacy. …”
Get full text
Article -
253
-
254
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Published 2025-02-01“…In this study, we demonstrate that TNG908 selectively binds the PRMT5·MTA complex driving selective inhibition of PRMT5 in MTAP-null cancers, a mechanism that creates a large therapeutic index relative to first generation PRMT5 inhibitors that have alternative binding mechanisms that are not tumor-selective. Strong preclinical activity in multiple MTAP-deleted xenograft models, as well as demonstrated brain penetrance in preclinical models, support the potential for histology-agnostic clinical development of TNG908 in MTAP-deleted solid tumors, including CNS malignancies. …”
Get full text
Article -
255
-
256
Prediction and verification of the influence of the rs367781716 SN P on the interaction of ТАТА -binding protein with the promoter of the human АВСА9 gene
Published 2016-01-01“…This approach contributes to undervaluation of clinically relevant SNPs and to unnecessary computational expenses (on verification of neutral SNPs). Preclinical empirical verification of possible candidate SNP markers may eliminate neutral SNPs from the dataset. …”
Get full text
Article -
257
Assessment of phytochemical screening, antibacterial, analgesic, and antipyretic potentials of Litsea glutinosa (L.) leaves extracts in a mice model.
Published 2025-01-01“…Additionally, the toxicity of the extracts was evaluated through preclinical testing.<h4>Results</h4>In hot plate method, the highest pain inhibitory activity was found at a dose of 500 mg/kg of crude extract (3.37 ± 0.31 sec) which differed significantly (P < 0.01 and P < 0.001) with that of the standard drug morphine (6.47 ± 0.23 sec). …”
Get full text
Article -
258
IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential
Published 2025-01-01“…Although research on the IL-33/ST2 signaling pathway has deepened recently, relevant treatment strategies have been proposed, and even targeted drugs are in the preclinical stage; further research on the effect of the IL-33/ST2 signaling pathway in different diseases is still necessary, to provide a clearer understanding of the different roles of IL-33/ST2 in disease progression and to develop new drugs and treatment strategies. …”
Get full text
Article -
259
Ozone Therapy on Rats Submitted to Subtotal Nephrectomy: Role of Antioxidant System
Published 2005-01-01Get full text
Article -
260
Progress in the structural modification and pharmacological activity of isosteviol
Published 2025-01-01“…This article briefly reviews the novel derivatives obtained through structural modification of isosteviol, including their pharmacological activities, to provide a reference for the development of new synthetic strategies and the construction of new isosteviol derivatives, and to guide preclinical studies and development of new drugs with greater pharmacological efficacy.…”
Get full text
Article